封面
市场调查报告书
商品编码
1935186

按产品类型、技术、应用和地区分類的生物降解支架市场

Biodegradable Scaffold Market, By Product Type, By Technology, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2026 年,可生物降解支架市场价值将达到 5.2 亿美元,到 2033 年将达到 11.65 亿美元,2026 年至 2033 年的复合年增长率为 12.2%。

报告覆盖范围 报告详情
基准年: 2025 2026年市场规模: 5.2亿美元
历史数据时期: 2020年至2024年 预测期: 2026年至2033年
预测期(2026-2033年)复合年增长率: 12.20% 2033 年的预测值: 11.65亿美元

随着研究人员不断革新递送方式、提升材料品质并拓展潜在医疗应用,可生物降解支架市场正在发生显着变化。组织工程、3D生物列印和聚合物科学领域的策略性进步在影响这些市场动态发挥关键作用。可生物降解支架通常由天然或合成聚合物构成,是骨再生、创伤治疗、心血管修復和牙科应用等快速发展领域的重要工具。

在结构设计中应用3D生物列印和先进奈米技术,可提高生物可降解支架的性能效率和稳定性。采用静电纺丝、个人化医疗和电脑辅助设计的现代化製造系统,能够促进细胞生长,提高手术成功率,并提升临床安全标准。这种转变为能够以低成本提供具有特定降解速率的高纯度生物可吸收材料的製造商创造了竞争优势。这些创新结构使医生能够透过提供临时支撑来治疗复杂的组织损伤,这些支撑在癒合后可被人体安全吸收。

市场动态

生物可降解支架市场正显着扩张,这主要归功于其在组织工程领域的重要角色。这些生物材料模板为新组织形成提供必要的支撑,降低长期植入排斥的风险,并促进有效的自然癒合。生物可降解支架在再生医学和临床产品中的应用日益广泛,这主要得益于其作为临时基质和生长调节剂的有效性,从而显着推动了市场需求。这些生物可吸收支架无需术后移除,即可促进受损表面的骨骼和皮肤再生,从而改善手术癒合。

此外,对高效创伤护理流程日益增长的需求是推动生物可降解支架市场成长的主要动力,因为它们在各种整形外科、牙科和心臟应用中发挥着至关重要的组织修復和调理作用。这些聚合物支架被广泛用于调节细胞环境,促进骨骼中钙等天然矿物质的形成,并促进组织重塑过程,从而改善患者的生活品质。药物传递、整形外科和肿瘤学等行业高度依赖工程组织,而工程组织需要生物可降解支架等材料来确保运作效率并符合安全标准。

全球对个人化和安全植入的需求日益增长,显着推动了可生物降解支架市场的发展,这主要归功于其在再生医学领域的广泛应用。这些可生物降解支架透过促进细胞增殖和蛋白质离子沉积来支撑组织,从而促进器官修復。这项特性不仅在大规模医院的外科部门至关重要,在专业研究系统中也同样重要,因为材料的品质直接影响修復效率和是否符合医疗法规。

本次调查的主要特点

  • 本报告对可生物降解支架市场进行了详细分析,以 2025 年为基准年,给出了预测期(2026-2033 年)内的市场规模和复合年增长率。
  • 我们将重点介绍各个细分市场的潜在商机,并说明该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
  • 根据以下参数对生物降解支架市场的主要企业进行了分析:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 生物降解支架市场报告涵盖了该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过各种用于分析生物降解支架市场的策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、监管与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 法规环境
  • 产品上市及核准情况
  • PEST分析
  • 波特分析
  • 市场机会
  • 法规环境
  • 重大进展
  • 产业趋势

4. 2020-2033年全球可生物降解支架市场(依产品类型划分)

  • 水凝胶
  • 聚合物支架
  • 基于奈米纤维的支架
  • 微图案化表面微孔盘

5. 2020-2033年全球可生物降解支架市场(依技术划分)

  • 去细胞技术
  • 合成支架
  • 3D列印
  • 其他的

6. 2020-2033年全球可生物降解支架市场(依应用领域划分)

  • 神经病学
  • 泌尿系统
  • 整形外科
  • 牙科
  • 心血管系统
  • 癌症
  • 皮肤/涂层
  • 胃肠病学/妇科
  • 其他的

7. 2020-2033年全球可生物降解支架市场(按地区划分)

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第八章 竞争情势

  • Merck KGaA
  • 3D Biotek LLC
  • Medtronic
  • Xanofi
  • Akron Biotech
  • Nanofiber Solutions
  • Vericel Corporation
  • NuVasive, Inc.
  • Organogenesis, Inc.
  • Biostage, Inc.
  • In2Bones Global
  • Orthofix Medical Inc.
  • Spine Smith
  • Invivo Therapeutics Holdings Corp.
  • Onkos Surgical

第九章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于本公司
简介目录
Product Code: CMI4734

Biodegradable Scaffold Market is estimated to be valued at USD 520 Mn in 2026 and is expected to reach USD 1,165 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 520 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 12.20% 2033 Value Projection: USD 1,165 Mn

The biodegradable scaffold market is evolving significantly as researchers reshape delivery methods, improve material quality, and broaden medical use possibilities. Strategic advancements in tissue engineering, 3D bioprinting, and polymer science play a critical role in influencing these market dynamics. Biodegradable scaffolds, which are typically composed of natural or synthetic polymers, are essential tools utilized in rapidly advancing fields such as bone regeneration, wound healing, cardiovascular repair, and dental applications.

The use of 3D bioprinting and advanced nanotechnology in structural design enhances the efficiency and consistency of biodegradable scaffold performance. Modern manufacturing systems employing electrospinning, personalized medicine, and computer-aided design lead to better cell growth, higher surgical success rates, and improved clinical safety standards. This shift creates a competitive edge for producers who supply high-purity, bioresorbable materials with specific degradation rates at lower production costs. These innovative structures allow doctors to treat complex tissue injuries by providing a temporary support that the body safely absorbs after healing.

Market Dynamics

The market for biodegradable scaffolds is expanding significantly, primarily due to their critical role in the tissue engineering sector. These biomaterial templates serve as essential support agents in the creation of new tissue. They reduce the risk of long-term implant rejection and facilitate effective natural healing. The increasing biodegradable scaffolds in regenerative medicine and clinical products are substantially propelling the demand within the market due to their efficacy as a temporary matrix and growth regulator. These bioresorbable frameworks improve the healing power of surgeries by neutralizing the need for follow-up removals and enabling better regrowth of bone and skin across damaged surfaces.

Furthermore, the rising demand for effective wound care processes is significantly propelling the growth of the biodegradable scaffold market, owing to its crucial role in repairing and conditioning tissue for various orthopedic, dental, and cardiac applications. These polymeric supports are widely used to adjust the environment of cells, precipitate the formation of natural minerals like calcium in bones, and facilitate remodeling processes that improve patient quality. Industries such as drug delivery, plastic surgery, and oncology heavily rely on engineered tissue, which often necessitates materials like biodegradable scaffolds to ensure operational efficiency and meet safety standards.

The increasing global demand for personalized and safe implants is significantly contributing to the growth of the biodegradable scaffold market, mainly because of its extensive use in regenerative therapy processes. These bio-scaffolds are extensively used to support tissue by precipitating cell growth and protein ions, which are responsible for organ recovery. This function is critical not only in large hospital surgical units but also in specialized research systems, where the quality of the material directly impacts recovery efficiency and compliance with healthcare regulations.

Key Features of the Study

  • This report provides in-depth analysis of the biodegradable scaffold market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the biodegradable scaffold market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck KGaA, 3D Biotek LLC, Medtronic, Xanofi, Akron Biotech, Nanofiber Solutions, Vericel Corporation, NuVasive, Inc., Organogenesis, Inc., Biostage, Inc., In2Bones Global, Orthofix Medical Inc., Spine Smith, Invivo Therapeutics Holdings Corp., and Onkos Surgical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The biodegradable scaffold market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Biodegradable scaffold market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2020 - 2033)
    • Hydrogels
    • Polymeric Scaffolds
    • Nanofiber Based Scaffolds
    • Micropatterned Surface Microplates
  • Technology Insights (Revenue, USD Mn, 2020 - 2033)
    • Decellularized Technology
    • Synthetic Scaffold
    • 3D Printing
    • Others
  • Application Insights (Revenue, USD Mn, 2020 - 2033)
    • Neurology
    • Urology
    • Orthopedics
    • Dental
    • Cardiology & Vascular
    • Cancer
    • Skin & Integumentary
    • Gastroenterology & Gynecology
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
  • Key Players Insights
    • Merck KGaA
    • 3D Biotek LLC
    • Medtronic
    • Xanofi
    • Akron Biotech
    • Nanofiber Solutions
    • Vericel Corporation
    • NuVasive, Inc.
    • Organogenesis, Inc.
    • Biostage, Inc.
    • In2Bones Global
    • Orthofix Medical Inc.
    • Spine Smith
    • Invivo Therapeutics Holdings Corp.
    • Onkos Surgical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biodegradable Scaffold Market, By Product Type
    • Global Biodegradable Scaffold Market, By Technology
    • Global Biodegradable Scaffold Market, By Application
    • Global Biodegradable Scaffold Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Biodegradable Scaffold Market, By Product Type, 2020-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hydrogels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Polymeric Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Nanofiber Based Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Micropatterned Surface Microplates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

5. Global Biodegradable Scaffold Market, By Technology, 2020-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Decellularized Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Synthetic Scaffold
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • 3D Printing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Biodegradable Scaffold Market, By Application, 2020-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Urology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Cardiology & Vascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Skin & Integumentary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Gastroenterology & Gynecology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

7. Global Biodegradable Scaffold Market, By Region, 2020 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technology, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 3D Biotek LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Xanofi
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akron Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanofiber Solutions
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vericel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NuVasive, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organogenesis, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biostage, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • In2Bones Global
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Orthofix Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Spine Smith
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Invivo Therapeutics Holdings Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Onkos Surgical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us